Samuel Achilefu

Southwestern Medical Center

Engineering · Physical Sciences

72h-index20.0kcitations530works1.42yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Nanoplatforms for cancer theranostics(131), Photodynamic Therapy Research Studies(73), Optical Imaging and Spectroscopy Techniques(70), Photoacoustic and Ultrasonic Imaging(60), Advanced biosensing and bioanalysis techniques(38)

Publications530 total

Anatomically constrained liver CT anomaly detection using healthy priors with diffusion-based inpainting

2026Open Access

Homing and Detection of Unknown Primary Head-Neck Cancer by Acid-Sensing Nanoparticles

2025Open Access

Table S6 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S5 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S2 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Figures S1-S8 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S3 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S4 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Table S1 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

2025Open Access

Chemo-RaST with bortezomib inhibits multiple myeloma relapse

1 cited

Theranostics·2025· 1 citedOpen Access

Low-cost parallax-free coaligned thermal and visible imaging with a visible/near-infrared and long-wave infrared beamsplitter (Conference Presentation)

2025

Cancer-targeted pro-theranostic bi-metallic organo-coordination nanoparticles

7 cited

Theranostics·2024· 7 citedOpen Access

5H7c: A rabbit monoclonal antibody detecting ferroptotic cells

5 cited

Molecular Cell·2024· 5 cited

Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages

19 cited

Nature Cancer·2024· 19 citedOpen Access

Frugal engineering-inspired wearable augmented reality goggle system enables fluorescence-guided cancer surgery

3 cited

Scientific Reports·2024· 3 citedOpen Access

Table S6 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S2 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Data from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S4 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

Table S1 from Breast cancer mutations HER2 V777L and PIK3CA H1047R activate the p21-CDK4/6 –Cyclin D1 axis driving tumorigenesis and drug resistance.

2024Open Access

page 1 of 27Next →

Frequent Co-authors

Walter J. Akers(11), Sharon Bloch(7), Yueqing Gu(6), М. Б. Березин(5), Sisi Cui(4), Gail Sudlow(4), Richard B. Dorshow(4), Baogang Xu(4), Joseph E. Bugaj(3), Raghavan Rajagopalan(3), Junmei Tian(3), Rui Tang(3), Hyeran Lee(3), Chulhong Kim(3), Lihong V. Wang(3), Joseph P. Culver(3), Kexian Liang(3), Yunpeng Ye(3), Orr Ashenberg(2), Ethan Cerami(2)